- Filed
- Jan 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Jan 16, 2026 | 34.05M sh |
| Shares Diluted | Q2 2026 · Nov 1, 2025 | 34.54M sh |
| Shares Diluted | Q2 2026 · Nov 1, 2025 | 34.48M sh |
| Shares Diluted restated | Q2 2026 · Oct 26, 2024 | 26.54M sh |
| Shares Diluted restated | Q2 2026 · Oct 26, 2024 | 20.02M sh |
| Stock Repurchased | Q2 2026 · Nov 1, 2025 | $0 |
| Stock Repurchased | Q2 2026 · Oct 26, 2024 | $4K |
| Capex | Q2 2026 · Nov 1, 2025 | $8.05M |
| Capex restated | Q2 2026 · Oct 26, 2024 | $7.02M |
| Operating Cash Flow | Q2 2026 · Nov 1, 2025 | −$1.36M |
| Operating Cash Flow restated | Q2 2026 · Oct 26, 2024 | −$96.09M |
| Long Term Debt | Q2 2026 · Nov 1, 2025 | $122.5M |
| Long Term Debt | Q2 2026 · May 3, 2025 | $103.1M |
| Cash And Equivalents | Q2 2026 · Nov 1, 2025 | $11.72M |
| Cash And Equivalents | Q2 2026 · May 3, 2025 | $9.06M |
| Stockholders Equity | Q2 2026 · Nov 1, 2025 | $283.24M |
| Stockholders Equity | Q2 2026 · Aug 2, 2025 | $256.45M |
| Stockholders Equity | Q2 2026 · May 3, 2025 | $272.19M |
| Stockholders Equity restated | Q2 2026 · Oct 26, 2024 | $211.44M |
| Stockholders Equity restated | Q2 2026 · Jul 27, 2024 | $149.78M |
| Stockholders Equity restated | Q2 2026 · Apr 27, 2024 | $80.4M |
| Current Liabilities | Q2 2026 · Nov 1, 2025 | $525.41M |
| Current Liabilities | Q2 2026 · May 3, 2025 | $279.23M |
| Total Liabilities | Q2 2026 · Nov 1, 2025 | $780.15M |
| Total Liabilities | Q2 2026 · May 3, 2025 | $518.1M |
| Current Assets | Q2 2026 · Nov 1, 2025 | $743.17M |
| Current Assets | Q2 2026 · May 3, 2025 | $465.39M |
| Total Assets | Q2 2026 · Nov 1, 2025 | $1.06B |
| Total Assets | Q2 2026 · May 3, 2025 | $790.29M |
| Eps Diluted | Q2 2026 · Nov 1, 2025 | $0.72 |
| Eps Diluted | Q2 2026 · Nov 1, 2025 | $0.19 |
| Eps Diluted restated | Q2 2026 · Oct 26, 2024 | $1.63 |
| Eps Diluted restated | Q2 2026 · Oct 26, 2024 | −$3.04 |
| Eps Basic | Q2 2026 · Nov 1, 2025 | $0.73 |
| Eps Basic | Q2 2026 · Nov 1, 2025 | $0.20 |
| Eps Basic restated | Q2 2026 · Oct 26, 2024 | $1.63 |
| Eps Basic restated | Q2 2026 · Oct 26, 2024 | −$3.04 |
| Sga Expense | Q2 2026 · Nov 1, 2025 | $77.3M |
| Sga Expense | Q2 2026 · Nov 1, 2025 | $145.16M |
| Sga Expense | Q2 2026 · Oct 26, 2024 | $72.94M |
| Sga Expense | Q2 2026 · Oct 26, 2024 | $139.96M |
| Net Income | Q2 2026 · Nov 1, 2025 | $25M |
| Net Income | Q2 2026 · Nov 1, 2025 | $6.73M |
| Net Income | Q2 2026 · Aug 2, 2025 | −$18.27M |
| Net Income restated | Q2 2026 · Oct 26, 2024 | $43.16M |
| Net Income restated | Q2 2026 · Oct 26, 2024 | −$60.76M |
| Net Income restated | Q2 2026 · Jul 27, 2024 | −$103.93M |
| Operating Income | Q2 2026 · Nov 1, 2025 | $40.8M |
| Operating Income | Q2 2026 · Nov 1, 2025 | $17.63M |
| Operating Income restated | Q2 2026 · Oct 26, 2024 | $47.15M |
| Operating Income restated | Q2 2026 · Oct 26, 2024 | $8.43M |
| Gross Profit | Q2 2026 · Nov 1, 2025 | $129.84M |
| Gross Profit | Q2 2026 · Nov 1, 2025 | $185.21M |
| Gross Profit restated | Q2 2026 · Oct 26, 2024 | $128.48M |
| Gross Profit restated | Q2 2026 · Oct 26, 2024 | $173.47M |
| Cost Of Revenue | Q2 2026 · Nov 1, 2025 | $514.58M |
| Cost Of Revenue | Q2 2026 · Nov 1, 2025 | $747.36M |
| Cost Of Revenue restated | Q2 2026 · Oct 26, 2024 | $473.65M |
| Cost Of Revenue restated | Q2 2026 · Oct 26, 2024 | $692.08M |
| Revenue | Q2 2026 · Nov 1, 2025 | $598.21M |
| Revenue | Q2 2026 · Nov 1, 2025 | $872.39M |
| Revenue | Q2 2026 · Oct 26, 2024 | $559.67M |
| Revenue | Q2 2026 · Oct 26, 2024 | $810.6M |